BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38293998)

  • 1. Predicting Progestin Therapy Response With PTEN, PAX2, and β-Catenin in Patients With Endometrioid Precancer.
    Liu N; Lin W; Wang Y; Yao Z; Rivera-Colon G; Li Y; Carrick KS; Chen H; Lucas E; Zheng W
    Int J Gynecol Pathol; 2024 Jan; ():. PubMed ID: 38293998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of a PAX2, PTEN, and β-catenin Panel in the Diagnosis of Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia in Endometrial Polyps.
    Lucas E; Niu S; Aguilar M; Molberg K; Carrick K; Rivera-Colon G; Gwin K; Wang Y; Zheng W; Castrillon DH; Chen H
    Am J Surg Pathol; 2023 Sep; 47(9):1019-1026. PubMed ID: 37314146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific Biomarker Expression Patterns in the Diagnosis of Residual and Recurrent Endometrial Precancers After Progestin Treatment: A Longitudinal Study.
    Chen H; Lucas E; Strickland AL; Carrick K; Gwin K; Castrillon DH; Rivera-Colon G; Niu S; Molberg KH; Zheng W
    Am J Surg Pathol; 2020 Oct; 44(10):1429-1439. PubMed ID: 32931681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliable Identification of Endometrial Precancers Through Combined Pax2, β-Catenin, and Pten Immunohistochemistry.
    Aguilar M; Chen H; Rivera-Colon G; Niu S; Carrick K; Gwin K; Cuevas IC; Sahoo SS; Li HD; Zhang S; Zheng W; Lucas E; Castrillon DH
    Am J Surg Pathol; 2022 Mar; 46(3):404-414. PubMed ID: 34545858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-catenin, Pax2, and Pten Panel Identifies Precancers Among Histologically Subdiagnostic Endometrial Lesions.
    Aguilar M; Chen H; Sahoo SS; Zheng W; Grubman J; SoRelle JA; Lucas E; Castrillon DH
    Am J Surg Pathol; 2023 May; 47(5):618-629. PubMed ID: 36939046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the prognostic value of PAX2 and PTEN in endometrial carcinogenesis.
    Rewcastle E; Varhaugvik AE; Gudlaugsson E; Steinbakk A; Skaland I; van Diermen B; Baak JP; Janssen EAM
    Endocr Relat Cancer; 2018 Dec; 25(12):981-991. PubMed ID: 30400021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of PTEN and beta-catenin for endometrial intraepithelial neoplasia in Japanese women.
    Norimatsu Y; Moriya T; Kobayashi TK; Sakurai T; Shimizu K; Tsukayama C; Ohno E
    Ann Diagn Pathol; 2007 Apr; 11(2):103-8. PubMed ID: 17349568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morules But Not Squamous Differentiation are a Reliable Indicator of CTNNB1 (β-catenin) Mutations in Endometrial Carcinoma and Precancers.
    Niu S; Lucas E; Molberg K; Strickland A; Wang Y; Carrick K; Rivera-Colon G; Gwin K; SoRelle JA; Castrillon DH; Zheng W; Chen H
    Am J Surg Pathol; 2022 Oct; 46(10):1447-1455. PubMed ID: 35834400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lesions sub-diagnostic of endometrioid intra-epithelial neoplasia/atypical hyperplasia: value of morphology and immunohistochemistry in predicting neoplastic outcome.
    Wyvekens N; Mutter GL; Nucci MR; Kolin DL; Parra-Herran C
    Histopathology; 2024 May; ():. PubMed ID: 38785042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions].
    Xiong Y; Xiong YY; Zhou YF
    Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):594-9. PubMed ID: 20079187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of PAX2 and PTEN Correlates to Therapy Response in Endometrial Hyperplasia.
    Ørbo A; Arnes M; Lyså LM; Straume B
    Anticancer Res; 2015 Dec; 35(12):6401-9. PubMed ID: 26637849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and significance of beta-catenin, Glut-1 and PTEN in proliferative endometrium, endometrial intraepithelial neoplasia and endometrioid adenocarcinoma.
    Xiong Y; Xiong YY; Zhou YF
    Eur J Gynaecol Oncol; 2010; 31(2):160-4. PubMed ID: 20527231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer.
    Monte NM; Webster KA; Neuberg D; Dressler GR; Mutter GL
    Cancer Res; 2010 Aug; 70(15):6225-32. PubMed ID: 20631067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PI3K Pathway Effectors pAKT and FOXO1 as Novel Markers of Endometrioid Intraepithelial Neoplasia.
    Strickland AL; Rivera G; Lucas E; John G; Cuevas I; Castrillon DH
    Int J Gynecol Pathol; 2019 Nov; 38(6):503-513. PubMed ID: 30256235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of PTEN and β-Catenin and Their Relationship With Clinicopathological and Prognostic Factors in Endometrioid Type Endometrial Cancer.
    Sal V; Demirkiran F; Erenel H; Tokgozoglu N; Kahramanoglu I; Bese T; Turan H; Sofiyeva N; Calay Z; Arvas M; Guralp O
    Int J Gynecol Cancer; 2016 Mar; 26(3):512-20. PubMed ID: 26894937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN as a predictive marker of response to conservative treatment in endometrial hyperplasia and early endometrial cancer. A systematic review and meta-analysis.
    Travaglino A; Raffone A; Saccone G; Insabato L; Mollo A; De Placido G; Zullo F
    Eur J Obstet Gynecol Reprod Biol; 2018 Dec; 231():104-110. PubMed ID: 30342311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression.
    Roh MH; Yassin Y; Miron A; Mehra KK; Mehrad M; Monte NM; Mutter GL; Nucci MR; Ning G; Mckeon FD; Hirsch MS; Wa X; Crum CP
    Mod Pathol; 2010 Oct; 23(10):1316-24. PubMed ID: 20562848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of clinicopathological factors to predict prognosis of fertility-sparing treatment for endometrial endometrioid carcinoma and atypical hyperplasia.
    Zhang X; Zhao X; Wang C; Lu S; Wang Y; He Y; Wang J; Shen D
    Oncol Lett; 2023 Feb; 25(2):52. PubMed ID: 36644134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear expression of β-catenin in endometrial hyperplasia as marker of premalignancy.
    Travaglino A; Raffone A; Saccone G; Mascolo M; D'Alessandro P; Arduino B; Mollo A; Insabato L; Zullo F
    APMIS; 2019 Nov; 127(11):699-709. PubMed ID: 31403731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathologic diagnosis of endometrial precancers: Updates and future directions.
    Chen H; Strickland AL; Castrillon DH
    Semin Diagn Pathol; 2022 May; 39(3):137-147. PubMed ID: 34920905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.